URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Peter Kouides

Concepts (298)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Menorrhagia
21
2001
28
7.290
Why?
von Willebrand Diseases
15
1998
23
5.730
Why?
Hemostasis
8
1998
61
3.470
Why?
Hemophilia A
7
2009
38
2.890
Why?
Hemorrhage
9
2001
181
2.830
Why?
Blood Coagulation Disorders
8
2002
37
1.960
Why?
Menstruation
6
1998
16
1.550
Why?
Coagulants
2
2008
13
1.510
Why?
Antifibrinolytic Agents
5
2008
17
1.420
Why?
Hemostatics
6
2006
21
1.380
Why?
Delivery of Health Care
2
2009
157
1.220
Why?
Humans
72
1988
37165
1.200
Why?
Heparin
2
2005
124
1.150
Why?
Physician's Practice Patterns
2
2009
268
1.130
Why?
Tranexamic Acid
4
2008
7
1.130
Why?
Deamino Arginine Vasopressin
5
2006
24
1.100
Why?
Anticoagulants
2
2005
141
1.100
Why?
Factor X Deficiency
2
2001
2
1.080
Why?
Factor VIII
4
2009
107
1.020
Why?
Blood Coagulation Factors
5
2001
52
1.010
Why?
Uterine Hemorrhage
2
2004
26
1.000
Why?
Female
43
1993
20222
0.970
Why?
Hemophilia B
2
2009
13
0.930
Why?
Biopsy
2
2006
384
0.900
Why?
Myelodysplastic Syndromes
5
1992
132
0.900
Why?
Blood Loss, Surgical
2
2008
45
0.880
Why?
Antibodies, Monoclonal
2
2006
748
0.830
Why?
Blood Platelet Disorders
3
2004
7
0.800
Why?
Thrombosis
1
2012
196
0.730
Why?
Polyps
1
2009
9
0.730
Why?
Factor IX
1
2009
12
0.730
Why?
Perioperative Care
1
2009
24
0.720
Why?
Postoperative Hemorrhage
1
2009
19
0.710
Why?
Purpura, Thrombocytopenic
3
1995
15
0.700
Why?
Colonoscopy
1
2009
46
0.700
Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2008
93
0.700
Why?
Venous Thromboembolism
1
2009
28
0.690
Why?
Gastrointestinal Hemorrhage
1
2009
87
0.690
Why?
Factor X
1
2008
30
0.670
Why?
Platelet Function Tests
5
2004
14
0.650
Why?
Pregnancy Complications, Hematologic
4
2001
29
0.650
Why?
von Willebrand Factor
5
2008
67
0.650
Why?
Antineoplastic Combined Chemotherapy Protocols
4
1993
436
0.630
Why?
Adult
27
1988
11572
0.620
Why?
Lymphoma, T-Cell
1
2007
11
0.620
Why?
Registries
1
2008
218
0.610
Why?
Splenic Neoplasms
1
2007
11
0.610
Why?
Crohn Disease
1
2007
88
0.590
Why?
Women
1
2006
17
0.560
Why?
Prostatic Neoplasms
1
2012
540
0.560
Why?
Vasculitis, Leukocytoclastic, Cutaneous
1
2006
5
0.560
Why?
Liver Neoplasms
1
2007
155
0.550
Why?
Prevalence
4
2005
582
0.540
Why?
Leukemia, Myeloid, Acute
2
1999
183
0.520
Why?
Hysterectomy
1
2004
33
0.510
Why?
Embolization, Therapeutic
1
2004
37
0.490
Why?
Endometrium
1
2004
47
0.490
Why?
Thrombocytopenia
1
2005
77
0.490
Why?
Catheter Ablation
1
2004
81
0.460
Why?
Quality of Life
6
2000
528
0.460
Why?
Middle Aged
20
1993
10013
0.460
Why?
Male
23
1988
20139
0.420
Why?
Child
9
1995
4342
0.420
Why?
Pregnancy
7
1998
1941
0.390
Why?
Treatment Outcome
7
1993
2671
0.390
Why?
Genitalia, Female
1
2000
23
0.390
Why?
Genital Diseases, Female
1
2000
34
0.380
Why?
Administration, Oral
3
2009
314
0.380
Why?
6-Aminocaproic Acid
2
2009
8
0.380
Why?
Bone Marrow Transplantation
6
1993
201
0.370
Why?
Rare Diseases
2
2008
28
0.370
Why?
Adolescent
10
1993
5044
0.360
Why?
Antineoplastic Agents
1
2006
628
0.360
Why?
Granulocyte Colony-Stimulating Factor
2
1995
45
0.350
Why?
Young Adult
5
2008
1084
0.350
Why?
Forecasting
2
2009
188
0.340
Why?
Cytarabine
2
1995
93
0.320
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
1993
56
0.320
Why?
Mass Screening
3
2006
270
0.310
Why?
Blood Coagulation Tests
2
2004
40
0.290
Why?
Sulfhemoglobinemia
1
1996
1
0.290
Why?
Cyanosis
1
1996
4
0.290
Why?
Methylene Blue
1
1996
12
0.290
Why?
Flutamide
1
1996
26
0.290
Why?
Multiple Endocrine Neoplasia Type 1
1
1996
5
0.280
Why?
Antineoplastic Agents, Hormonal
1
1996
44
0.280
Why?
Blast Crisis
1
1995
19
0.270
Why?
Clinical Laboratory Techniques
2
2002
39
0.270
Why?
Cell Transformation, Neoplastic
2
1995
138
0.270
Why?
Red-Cell Aplasia, Pure
1
1995
9
0.270
Why?
Leukemia, Lymphoid
1
1995
64
0.270
Why?
Leukemia, Myelomonocytic, Chronic
1
1995
20
0.260
Why?
Pericarditis
1
1995
13
0.260
Why?
Questionnaires
4
2000
1061
0.260
Why?
Chromosomes, Human, Pair 18
1
1994
15
0.260
Why?
Chromosomes, Human, Pair 14
1
1994
17
0.260
Why?
Chromosomes, Human, Pair 19
1
1994
14
0.260
Why?
Aged
11
1993
7392
0.260
Why?
Chromosomes, Human, Pair 1
1
1994
26
0.250
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
1995
82
0.250
Why?
Burkitt Lymphoma
1
1994
53
0.250
Why?
Translocation, Genetic
1
1994
65
0.250
Why?
Leukemia
1
1995
158
0.240
Why?
Respiratory Distress Syndrome, Adult
1
1995
75
0.240
Why?
Postpartum Hemorrhage
3
2006
8
0.240
Why?
Contraceptives, Oral, Combined
2
2008
5
0.240
Why?
Immunosuppressive Agents
1
1995
206
0.230
Why?
Sex Characteristics
2
2001
141
0.220
Why?
Practice Guidelines as Topic
3
2009
319
0.220
Why?
Blood Coagulation Factor Inhibitors
1
2012
1
0.220
Why?
Chicago
1
2012
6
0.220
Why?
Hematology
2
2002
13
0.220
Why?
Retrospective Studies
4
1995
2302
0.220
Why?
Charcoal
1
2012
17
0.210
Why?
Antidotes
1
2012
17
0.210
Why?
Congresses as Topic
1
2012
35
0.210
Why?
Factor Xa
1
2012
40
0.210
Why?
Blood Coagulation Disorders, Inherited
1
2011
1
0.210
Why?
Prostate-Specific Antigen
1
2012
111
0.200
Why?
Hemorrhagic Disorders
1
2011
5
0.200
Why?
Epistaxis
1
2010
4
0.200
Why?
Hormone Replacement Therapy
1
2011
15
0.200
Why?
Thrombin
1
2012
150
0.200
Why?
Contusions
1
2010
22
0.190
Why?
Immune Tolerance
1
2011
150
0.190
Why?
Remission Induction
2
1995
165
0.190
Why?
Medical History Taking
1
2010
69
0.190
Why?
Vitamin K
1
2009
8
0.180
Why?
Upper Gastrointestinal Tract
1
2009
1
0.180
Why?
Helicobacter Infections
1
2009
11
0.180
Why?
Premedication
1
2009
21
0.180
Why?
Labor, Obstetric
2
1998
32
0.180
Why?
Platelet Transfusion
1
2010
86
0.180
Why?
Cyclooxygenase 2 Inhibitors
1
2009
62
0.180
Why?
Biomedical Research
1
2011
137
0.170
Why?
Iran
1
2008
4
0.170
Why?
Administration, Intranasal
1
2009
61
0.170
Why?
Deferoxamine
1
1988
17
0.170
Why?
Italy
1
2008
23
0.170
Why?
Headache
1
2009
52
0.170
Why?
Plasma
1
2008
33
0.170
Why?
Cross-Over Studies
1
2009
119
0.170
Why?
Prospective Studies
3
1993
1696
0.170
Why?
Homozygote
1
2008
95
0.170
Why?
Disease Management
3
2002
31
0.170
Why?
Great Britain
1
2008
100
0.160
Why?
Heterozygote
1
2008
127
0.160
Why?
Risk Factors
2
1998
2331
0.160
Why?
Mutation, Missense
1
2008
89
0.160
Why?
Placenta Diseases
1
2007
18
0.160
Why?
Hematologic Tests
1
2007
8
0.160
Why?
Evidence-Based Medicine
1
2009
210
0.160
Why?
Diagnosis, Differential
3
1997
889
0.160
Why?
Follow-Up Studies
3
1995
1889
0.150
Why?
Mastocytosis, Systemic
1
2007
4
0.150
Why?
Pneumonia, Pneumocystis
1
1988
121
0.150
Why?
Arteries
1
2007
80
0.150
Why?
Genotype
1
2008
473
0.150
Why?
Recombinant Proteins
1
2009
770
0.150
Why?
Menstruation Disturbances
1
2006
9
0.140
Why?
Randomized Controlled Trials as Topic
2
2004
415
0.140
Why?
Infant
2
2008
2320
0.140
Why?
Placenta
1
2007
143
0.140
Why?
Pain
1
2009
392
0.140
Why?
Lymphoma
2
1993
163
0.140
Why?
Injections, Intravenous
1
2006
133
0.140
Why?
Severity of Illness Index
2
1993
943
0.130
Why?
Antibodies, Monoclonal, Murine-Derived
1
2006
132
0.130
Why?
Lymphoma, Follicular
1
2006
61
0.130
Why?
Lymphoma, Non-Hodgkin
2
1995
113
0.130
Why?
Dexamethasone
1
2006
188
0.130
Why?
Anti-Inflammatory Agents
1
2006
115
0.130
Why?
Postoperative Period
1
2004
89
0.120
Why?
Heavy Chain Disease
1
2003
2
0.120
Why?
Immunoglobulin lambda-Chains
1
2003
20
0.120
Why?
Amyloidosis
1
2003
29
0.120
Why?
Thalassemia
2
1988
23
0.120
Why?
Immunoglobulin Heavy Chains
1
2003
47
0.120
Why?
Infant, Newborn
1
2008
1836
0.120
Why?
Skin
1
2006
384
0.110
Why?
Hodgkin Disease
2
1993
156
0.110
Why?
Premenopause
1
2002
13
0.110
Why?
Child, Preschool
4
1997
2737
0.110
Why?
Postmenopause
1
2002
42
0.110
Why?
Physical Examination
1
2002
91
0.100
Why?
Obstetric Labor Complications
1
2001
19
0.100
Why?
Home Infusion Therapy
1
2001
1
0.100
Why?
Transplantation, Homologous
2
1995
280
0.090
Why?
Prognosis
3
1993
1078
0.090
Why?
Meninges
1
1999
21
0.090
Why?
Fatal Outcome
2
1996
109
0.090
Why?
Multiple Myeloma
1
1999
75
0.090
Why?
Platelet Aggregation
2
2007
64
0.090
Why?
Flow Cytometry
2
1995
603
0.090
Why?
Corynebacterium Infections
1
1998
7
0.090
Why?
Meningeal Neoplasms
1
1999
51
0.090
Why?
Parvoviridae Infections
1
1998
12
0.080
Why?
Infectious Mononucleosis
1
1998
21
0.080
Why?
United States
3
2011
2847
0.080
Why?
Algorithms
1
2002
543
0.080
Why?
Risk Assessment
3
2002
875
0.080
Why?
Cohort Studies
2
2011
984
0.080
Why?
Anemia, Sideroblastic
1
1997
9
0.080
Why?
Copper
1
1997
52
0.070
Why?
Methemoglobinemia
1
1996
1
0.070
Why?
Anemia
1
1997
78
0.070
Why?
Brain Neoplasms
1
1999
282
0.070
Why?
Aged, 80 and over
2
1995
2588
0.070
Why?
Treatment Failure
1
1996
131
0.070
Why?
Daunorubicin
1
1995
25
0.070
Why?
Hypersensitivity, Delayed
1
1996
52
0.070
Why?
Sex Factors
1
1998
613
0.070
Why?
Case-Control Studies
2
2004
624
0.070
Why?
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor
1
1995
12
0.070
Why?
Recurrence
4
1993
697
0.070
Why?
Antineoplastic Agents, Alkylating
1
1996
44
0.070
Why?
Drug Hypersensitivity
1
1996
44
0.070
Why?
Clinical Trials as Topic
2
2008
685
0.070
Why?
Cyclophosphamide
1
1996
177
0.070
Why?
Immunophenotyping
1
1995
126
0.060
Why?
Hepatitis B
1
1995
19
0.060
Why?
Neoplasm Metastasis
1
1996
229
0.060
Why?
Hydroxyquinolines
1
1993
9
0.060
Why?
Acute Disease
2
1995
591
0.060
Why?
Bone Marrow
1
1994
292
0.060
Why?
Adjuvants, Immunologic
1
1993
118
0.050
Why?
Apoptosis
1
1999
855
0.050
Why?
Stem Cell Transplantation
1
1993
115
0.050
Why?
Drug Monitoring
1
2012
41
0.050
Why?
Drug Interactions
1
2012
186
0.050
Why?
Contraceptive Agents, Female
1
2011
3
0.050
Why?
Drug Combinations
1
2011
150
0.050
Why?
Hematologic Diseases
1
2011
40
0.050
Why?
Hematopoiesis
1
1992
129
0.050
Why?
Menstrual Cycle
1
2011
14
0.050
Why?
Transplantation, Autologous
3
1993
151
0.050
Why?
Protein C
1
2011
47
0.050
Why?
Population Surveillance
1
2011
144
0.050
Why?
Electrocardiography
1
1995
746
0.050
Why?
Longitudinal Studies
1
2011
413
0.040
Why?
Decision Trees
1
2009
30
0.040
Why?
Joint Diseases
1
2009
33
0.040
Why?
Liver Diseases
1
2009
80
0.040
Why?
Intrauterine Devices, Medicated
1
2008
1
0.040
Why?
Levonorgestrel
1
2008
3
0.040
Why?
Danazol
1
2008
4
0.040
Why?
Phenotype
1
2011
756
0.040
Why?
Kidney Failure, Chronic
1
2009
119
0.040
Why?
Progestins
1
2008
15
0.040
Why?
Hypertension, Malignant
1
2007
6
0.040
Why?
Hemostasis, Surgical
1
2008
11
0.040
Why?
Purpura, Thrombotic Thrombocytopenic
1
2007
11
0.040
Why?
Plasmapheresis
1
2007
26
0.040
Why?
ADAM Proteins
1
2007
14
0.040
Why?
Ticlopidine
1
2007
6
0.040
Why?
Plasma Exchange
1
2007
18
0.040
Why?
Gonadotropin-Releasing Hormone
1
2008
44
0.040
Why?
Pre-Eclampsia
1
2007
25
0.040
Why?
Comorbidity
1
2009
377
0.040
Why?
Aspirin
1
2007
59
0.040
Why?
Platelet Aggregation Inhibitors
1
2007
60
0.040
Why?
Drug Resistance
1
2007
100
0.040
Why?
Prednisone
1
2007
182
0.040
Why?
Drug Therapy, Combination
1
2007
397
0.040
Why?
Cardiovascular Diseases
1
2009
275
0.030
Why?
Coagulation Protein Disorders
1
2004
2
0.030
Why?
Fluorescent Antibody Technique, Direct
1
2003
8
0.030
Why?
Basement Membrane
1
2003
33
0.030
Why?
Kidney Glomerulus
1
2003
28
0.030
Why?
Nephrotic Syndrome
1
2003
27
0.030
Why?
Amyloid
1
2003
20
0.030
Why?
Reference Values
1
2004
453
0.030
Why?
Neoplasms
1
2009
743
0.030
Why?
Hematopoietic Stem Cell Transplantation
1
2003
133
0.030
Why?
Combined Modality Therapy
2
1993
491
0.030
Why?
Sensitivity and Specificity
1
2004
914
0.020
Why?
Granulocytes
1
1999
83
0.020
Why?
Bone Marrow Examination
1
1998
25
0.020
Why?
Blood Cell Count
1
1998
45
0.020
Why?
Radiotherapy
1
1999
198
0.020
Why?
Neoplasm, Residual
1
1997
21
0.020
Why?
Bone Marrow Cells
1
1998
222
0.020
Why?
Cerebral Cortex
1
1999
257
0.020
Why?
Skin Tests
1
1996
34
0.020
Why?
Immunoglobulin E
1
1996
56
0.020
Why?
Hepatitis B e Antigens
1
1995
2
0.020
Why?
Hepatitis B Surface Antigens
1
1995
7
0.020
Why?
Multivariate Analysis
1
1997
548
0.020
Why?
Antibodies
1
1996
220
0.020
Why?
Disease-Free Survival
1
1995
204
0.020
Why?
Actuarial Analysis
1
1993
21
0.020
Why?
Leukemia, Myeloid
1
1995
121
0.020
Why?
Survival Rate
1
1995
619
0.010
Why?
Proportional Hazards Models
1
1993
426
0.010
Why?
Predictive Value of Tests
1
1993
609
0.010
Why?
Survival Analysis
1
1993
589
0.010
Why?
Age Factors
1
1995
1152
0.010
Why?
Time Factors
1
1996
3234
0.010
Why?

Visualizations


Kouides's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department